(Q83768562)
Statements
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study (English)
Frank G Holz
Winfried Amoaku
Ulrich Kellner
Reinier O Schlingemann
Andreas Weichselberger
SUSTAIN Study Group